Open AccessAbstract 4527: Patient-derived organoids and xenografts identify neratinib plus HER2 antibody drug conjugate as a synergistic drug combination for HER2 mutated, nonamplified metastatic breast cancer
Author(s) -
Shunqiang Li,
Highkin Maureen,
Tina Primeau,
Stephanie L. Pratt,
Irmina Diala,
Richard E. Cutler,
Grace Mann,
Alshad S. Lalani,
X. Cynthia,
Ron Bose
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-4527
Subject(s) - neratinib , medicine , metastatic breast cancer , breast cancer , lapatinib , cancer , cancer research , oncology , population , ex vivo , trastuzumab , in vivo , biology , microbiology and biotechnology , environmental health